|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$48,561,124 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$48,561,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-38.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-05-09 |
4 |
OE |
$21.92 |
$175,360 |
D/D |
8,000 |
348,593 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-07-31 |
4 |
B |
$95.45 |
$176,583 |
D/D |
1,850 |
146,749 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-15 |
4 |
S |
$90.00 |
$180,000 |
D/D |
(2,000) |
367,180 |
0 |
% |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-18 |
4 |
OE |
$3.68 |
$184,000 |
D/D |
50,000 |
2,512,686 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2023-01-04 |
4 |
A |
$3.23 |
$186,704 |
D/D |
57,803 |
2,339,452 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2016-09-08 |
4 |
S |
$109.83 |
$186,716 |
D/D |
(1,700) |
1,359 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-08-17 |
4 |
OE |
$14.47 |
$188,009 |
D/D |
12,993 |
101,912 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2014-01-21 |
4 |
OE |
$21.00 |
$189,000 |
D/D |
9,000 |
111,099 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-18 |
4 |
S |
$3.89 |
$194,500 |
D/D |
(50,000) |
2,462,686 |
0 |
% |
|
TECH |
Techne Corp |
Director |
|
2022-08-11 |
4 |
S |
$380.71 |
$197,322 |
D/D |
(512) |
5,502 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-05-15 |
4 |
OE |
$16.14 |
$200,217 |
D/D |
12,405 |
119,824 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-11-09 |
4 |
D |
$81.77 |
$200,991 |
D/D |
(2,458) |
222,113 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-11-09 |
4 |
OE |
$10.05 |
$201,000 |
D/D |
20,000 |
224,571 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-02-15 |
4 |
D |
$85.97 |
$214,237 |
D/D |
(2,492) |
130,497 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2022-08-10 |
4 |
OE |
$66.90 |
$227,460 |
D/D |
3,400 |
8,006 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-10-13 |
4 |
D |
$143.04 |
$249,462 |
D/D |
(1,744) |
148,811 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-10-13 |
4 |
OE |
$21.92 |
$249,537 |
D/D |
11,384 |
150,555 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-09 |
4 |
OE |
$21.00 |
$252,000 |
D/D |
12,000 |
151,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-12-12 |
4 |
D |
$64.80 |
$255,571 |
D/D |
(3,944) |
432,984 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-12-12 |
4 |
OE |
$12.78 |
$255,600 |
D/D |
20,000 |
436,928 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-01-19 |
4 |
OE |
$16.14 |
$262,259 |
D/D |
16,249 |
162,299 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4 |
S |
$89.35 |
$268,050 |
D/D |
(3,000) |
364,180 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-05-14 |
4 |
B |
$113.50 |
$283,750 |
D/D |
2,500 |
143,899 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-03-13 |
4 |
B |
$114.29 |
$285,725 |
D/D |
2,500 |
141,399 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-07-07 |
4 |
OE |
$56.26 |
$302,098 |
D/D |
4,315 |
204,571 |
0 |
- |
|
165 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|